Nearly half of the women who undergo radical surgery for breast cancer that has spread to other parts of the body die within the next five years. Now the odds may soon shift sharply in favor of these cancer victims. Last week Italian doctors reported a new postoperative program of drug treatment that could increase the chances of survival from breast cancer as much as fivefold.
The pioneering therapy was developed by researchers at Milan's Istituto Nazionale Tumori, the Italian equivalent of the U.S. National Cancer Institute (which supported the study). Led by Dr. Gianni Bonadonna, who studied at Manhattan's Memorial Sloan-Kettering...
To continue reading:
or
Log-In
